Word: bayer
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...Worchester, Mass., banks and other companies have bought the naming rights to public libraries and high school football fields. The University of Wisconsin at Madison offers doctors and other health-care professionals an online continuing-education course on menstrual disorders that is funded by the pharmaceutical giant Bayer. While the class's title doesn't carry Bayer's name, the company's drugs are mentioned in the course, and the school fully acknowledges the arrangement in course materials...
...report based on evidence collected during January raids at the headquarters to some of the world's biggest drug companies, including U.S. companies Pfizer and Johnson & Johnson, Britain's GlaxoSmithKline, Anglo-Swedish giant AstraZeneca, and Sanofi-Aventis of France. The other companies known to be raided were Wyeth, Merck, Bayer Schering Pharma and Roche, as well as generic firms Teva and Sandoz...
...Nobody Does It Better," Carly Simon Carole Bayer Sager's words are legitimately sexy, while the music by Marvin Hamlisch uses every cliché in the composer's arsenal to build to a syrupy but irresistible coda...
...derive benefit from taking a statin. Longer-term trials are still needed, however, to show whether the benefits of statins outweigh their potential side effects - the drugs are relatively benign, but they are known in rare cases to cause debilitating side effects such as muscle weakness (which forced Bayer to pull its version off the market in 2001). There was no increase in side effects among JUPITER's study group, but because the trial was terminated early, researchers don't know whether they would have seen more adverse effects later on. It's also not clear whether all statins...
...With the cost of new-drug development hovering in the hundreds of millions of dollars, the pharmaceutical industry decided there wasn't enough of a market to make male hormonal contraceptives worthwhile. The German drug giant Schering halted its development program in 2006 (after its high-profile acquisition by Bayer), and other drug companies quickly followed suit, abandoning several projects that were - at least by the researchers' accounts - on the verge of success...